Let us help you "Get to Done"
We’ve been in your shoes. Let us help you find a better way.
Healthcare & Life Sciences
Insight Paper
April 2, 2024
Healthcare & Life Sciences | Products & Distribution
Exploring Federal PFAS Regulations
Kenneth Beymer shares a brief history and current state of US Federal PFAS Regulations.
Insight Paper
April 12, 2024
Healthcare & Life Sciences | Products & Distribution
First-Ever National Limits on PFAS in Drinking Water
Kenneth Beymer shares insights into the National Primary Drinking Water Regulation (NPDWR) rule established by the Environmental Protection Agency (EPA) on April 10, 2024.
Insight Paper
April 16, 2024
Weathering the Storm
Kenneth Beymer, Blake Ekblad, and Dylan Azadi assess the relationship between climate change and health inequity.
Case Study
May 1, 2024
Managing, Monitoring, and Governing Data with Trading Partners
Trexin helped a large health insurer develop an external data management system.
Insight Paper
May 7, 2024
Healthcare & Life Sciences | Products & Distribution
Exploring State-Level PFAS Regulations
Kenneth Beymer provides a summary of current state regulations around PFAS and what they mean.
Insight Paper
May 14, 2024
Healthcare & Life Sciences | Products & Distribution
Exploring PFAS Use in Medical Technology
Bo Youman shares a brief summary into the role of PFAS in the Medical Technology industry.
Case Study
May 29, 2024
Improving Health Equity Outcomes Through Data Governance
Trexin implemented data strategy tactics to help a large Healthcare Payer gather, analyze, and leverage Race, Ethnicity, and Language (REL) data to personalize care services for underserved populations.
Insight Paper
June 4, 2024
Healthcare & Life Sciences | Products & Distribution
PFAS Impacts on the Supply Chain
Zach Willett shares his thoughts on the impacts of regulations, manufacturing changes, and PFAS discontinuations on the supply chain.
Insight Paper
June 25, 2024
Healthcare Interoperability – What is in “The Final Rule”?
Fatima Zehra shares important dates and capability impacts medical data providers and healthcare exchanges should know about.